Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)

JACCRO and KCSG Study Group, The; Koizumi, Wasaburo; Hong Kim, Yeul; Fujii, Masashi; Kyo Kim, Hoon; Imamura, Hiroshi; Hee Lee, Kyung; Hara, Takuo; Cheol Chung, Hyun; Satoh, Taroh; Choi, Y.; Hosaka, Hisashi; Tsuji, Akihito; Takagane, Akinori; Inokuchi, Mikito; Tanabe, Kazuaki; Okuno, Tatsuya; Ogura, Mariko; Yoshida, Kazuhiro; Takeuchi, Masahiro; Nakajima, Toshifusa

doi:10.1007/s00432-013-1563-5

Public

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)

Shared by NobleBlocks on Dec 23, 2013 • 12:00 AM UTC

Authors:

The JACCRO and KCSG Study Group

Wasaburo Koizumi

Yeul Hong Kim

Abstract

PURPOSE: Cisplatin plus 5-fluorouracil has been globally accepted as a standard regimen for the treatment for advanced gastric cancer. However, cisplatin has several disadvantages, including renal toxicity and the need for admission. S-1 plus cisplatin has become a standard treatment for advanced ga...

Subject

Docetaxel

Medicine

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!